I think nearly everyone was aware 6 months ago that a CR was going to occur after the release of the phase 2 -201 data. I knew, and i'm generally the last to know. The nitty gritty details of the CR were not (are not) important to those who were never going to be able to participate, so why be so concerned? I for one am being kept well informed by the company as to what is currently going on, and what the plans are going forward. Certainly can't call me a mushroom when it comes to Alterity.
- Forums
- ASX - By Stock
- ATH
- Tranche 2 voting
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.1¢

Tranche 2 voting, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 11430464 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 9123329 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 11430464 | 0.010 |
26 | 26394228 | 0.009 |
15 | 28140963 | 0.008 |
13 | 24058106 | 0.007 |
14 | 8953518 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 9164745 | 10 |
0.012 | 22384784 | 29 |
0.013 | 8080040 | 15 |
0.014 | 13188180 | 7 |
0.015 | 2059976 | 9 |
Last trade - 09.59am 18/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online